MedPath

A randomised, controlled, double-blind trial to investigate the effects of a new infant formula on growth, tolerance and safety in healthy term infants.

Phase 2
Completed
Conditions
effect op de groei van zuigelingen
effects on growth
Registration Number
NL-OMON39783
Lead Sponsor
utricia Research - Centre for Specialised Nutrition
Brief Summary

Trial is onging in other countries

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
121
Inclusion Criteria

Healthy term infants (gestational age >= 37 1/7 and <= 42 6/7 weeks) - Age <= 35 days (preferably as soon as possible after birth) - Birth weight within normal range for gestational age and sex (10th to 90th percentile according to local applicable growth charts) - Infants who are exclusively formula fed (mothers who have chosen not to breastfeed or mothers who ended breastfeeding by time of inclusion) or - Infants who are exclusively breastfed and whose mothers are willing to exclusively breastfeed at least till their infant is 13 weeks of age (and preferably till 17 weeks of age).
For the sub-study:
Once 176 infants receiving study product have been included in the main study, inclusion in the sub-study will start. The inclusion criterium **Age <= 35 days (preferably as soon as possible after birth)** will no longer be valid and be replaced by: **Age <= 14 days (preferably as soon as possible after birth)**.

Exclusion Criteria

- Infants known to have current or previous illnesses/conditions or intervention which could interfere with the study or its outcome parameters, such as gastrointestinal malformations, congenital metabolic disorders, immune deficiency or major surgery, as per investigator*s clinical judgement - Infants whose mother is known to suffer from hepatitis B or human immunodeficiency virus (HIV)

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>Weight gain in grams per day from randomisation until 17 weeks of age [g/day]. </p><br>
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath